BioSpace News Archive

Cordance Medical, a pioneering medical device company focused on opening the Blood-Brain Barrier (BBB) to facilitate liquid biopsy, announces that its NeuroAccess™ device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 62 cents per share of common stock.

Harmony Biosciences Holdings, Inc. has selected the latest round of nonprofit organizations for its Patients at the Heart and Progress at the Heart awards.

Seraxis, Inc., a regenerative medicine company developing pancreatic islet replacement therapies to transform the lives of patients with Type 1 and insulin-requiring Type 2 diabetes, today announced the publication in bioRxiv of “Pancreatic Endocrine cell clusters derived from a non-pluripotent stem cell capable of regulating blood glucose in animal models of diabetes.”

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.

Edgewise Therapeutics, Inc. today announced an expansion of their clinical development program of EDG-5506.

Blue Life Solutions, a pioneering contract medical device manufacturing company specializing in sample collection devices, announced the receipt of its ISO 13485:2016 certification.

enVVeno Medical Corporation today reported financial results for the third quarter ended September 30, 2023.

Personalis, Inc., a leader in advanced genomics for precision oncology, announced the launch of the Early Access Program for NeXT Personal Dx, a tumor-informed, whole genome-based liquid biopsy laboratory developed test for detection of molecular residual disease and recurrence in cancer.

Evaxion Biotech A/S is proud to announce that it will be presenting clinical readouts on its two personalized cancer vaccine trials at SITC’s 38th annual meeting, taking place in San Diego, California from November 1-5, 2023.